Dr. Alireza Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Netherlands, Russia, France, Swiss, Germany, Sweden, Italy, Spain, Portugal, Mexico, Taiwan, South Korea, China, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore.
Alireza Heidari(Research Area)
Ab initio & Density Functional Methods
1)synthesis and chemistry of five-membered heterocycles and natural products containing such units
2)synthesis and chemistry of fungal metabolites
synthesis and chemistry of cyclopeptide alkaloids
3)synthesis of biologically important depsipeptides
4)synthesis of novel ninhydrins
synthesis of anti- angiogenic agents.
Svetlana (Lana) Mikhaylichenko graduated with first class honors from the Kuban State Technological University (Russia, Krasnodarskiy kray) in 1985. She completed her Doctoral Program at Kuban State Agrarian University in 1996 and joined the Department of Organic and Physical Chemistry in the same year as a Lecturer. In 2003 her family immigrated to Canada. Dr. Mikhaylichenko joined the Department of Physical and Environmental Sciences (DPES) University of Toronto Scarborough (UTSC) in early 2004 as a Chemistry Technician. In 2008 Dr. Mikhaylichenko hired by DPES in a rank of a full time Lecturer. Lana Mikhaylichenko is currently an Associate Professor, Teaching Stream at this department. She serves DPES as an Associate Chair Undergraduate studies staring from September 2016. Whilst teaching a range of undergraduate courses, she was nominated for several awards since joining UTSC. Dr. Mikhaylichenko is a recipient of University of Toronto Scarborough Outstanding Teaching Award in 2014, UTSC D.R. Campbell Merit Award in 2008, and numerous University of Toronto Scarborough Deanâ€™s Merit Excellence Awards.
Professor Kanwar is the group leader and laboratory head of Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research in School of Medicine, Faculty of Health at Deakin University. His earlier research (for nearly a decade in New Zealand) has focused on studying pathophysiology and devising new treatments mainly for cancer and chronic inflammatory diseases. Prof. Kanwar is currently working on nanotechnology/nanomedicine based protein/peptide, aptamers and his research approach employs monotherapy (gene therapy, immunotherapy) and combinational therapy with commercially available chemotherapeutic agents including LNA-aptamers (RNA/DNA), peptides and other biomolecules such as siRNA, miRNA, aptamers, proteins, siRNA, miRNA and their chimera (LNA-aptamer chimera with siRNA/miRNA delivery for targeting expression of survivin (the validated anti-cancer target), HIF-1 and apoptotic signalling moleculesâ€™ in cancer and chronic inflammation.
Jagat Rakesh Kanwar (Research Area)
An immense focus of the group is to develop non-conventional therapeutics involving compounds for cancer and other inflammatory diseases. Nanomedicine is the need for the day to develop, synthesise and characterize of nanoformulations that can achieve a more targeted and specific delivery system is being carried out in the NLIMBR laboratory. Extensive research is carried out for development and physio-chemical characterization of biodegradable and biocompatible drug delivery vehicles. Novel targeted delivery systems possessing enhanced permeation retention effect, stability and narrow size range have been successfully synthesised. A number of other developments including microfluidics, nanodevices, nanosensers and microchips for targeted delivery and diagnosis are also our major interests. The principle aim is to achieve a system where there is a diagnostic and therapeutic approach to target cancer and other inflammatory conditions. Recently microfluidic systems being worked upon are targeting an approach to less time consuming and more economic methods for cancer and microbial infection diagnosis.
IstvÃ¡n T. HorvÃ¡th is a Hungarian American chemist, working on greener and more sustainable chemistry since its inception.In particular, he focuses on homogeneous transition metal catalysis and in situ spectroscopy. He was highly involved and very influential in the now enormous field of fluorous solvents and technologies.
Istvan T. Horvath(Research Area)
As of 2015 his research lies in the conversion of biomass into platform chemicals, and the development of more sustainable fluorous solvent-based processes. He proposed that gamma-Valerolactone (GVL) exhibits the most important characteristics of a sustainable liquid and it can be used for the production of both energy and carbon-based consumer products. It was confirmed by isotope labeling that fructose can be converted to hydroxymethylfurfural (HMF) then to levulinic acid (LA) and formic acid (FA) and finally to GVL in GVL as the solvent. He is also the editor of numerous books and other peer-reviewed publications in the fields of catalysis, green chemistry, and fluorous technologies.
Dr. Al-Kinany holds Ph.D. in heterogeneous and homogeneous catalysis from university of Manchester.He is now associated as Specialist scientific with National Center for Petrochemicals Technology, KACSTâ€“ Saudi Arabia.